Skadden is advising Valeant Pharmaceuticals International, Inc. on financing and antitrust aspects of its $14.5 billion acquisition of Salix Pharmaceuticals, Ltd., announced February 22.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates